Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;38(9):1715-1721.
doi: 10.1016/j.ajem.2020.06.011. Epub 2020 Jun 6.

Dermatologic manifestations and complications of COVID-19

Michael Gottlieb  1 , Brit Long  2
Affiliations
Review

Dermatologic manifestations and complications of COVID-19

Michael Gottlieb et al. Am J Emerg Med. 2020 Sep.

Abstract

The novel coronavirus disease of 2019 (COVID-19) is associated with significant morbidity and mortality. While much of the focus has been on the cardiac and pulmonary complications, there are several important dermatologic components that clinicians must be aware of.

Objective: This brief report summarizes the dermatologic manifestations and complications associated with COVID-19 with an emphasis on Emergency Medicine clinicians.

Discussion: Dermatologic manifestations of COVID-19 are increasingly recognized within the literature. The primary etiologies include vasculitis versus direct viral involvement. There are several types of skin findings described in association with COVID-19. These include maculopapular rashes, urticaria, vesicles, petechiae, purpura, chilblains, livedo racemosa, and distal limb ischemia. While most of these dermatologic findings are self-resolving, they can help increase one's suspicion for COVID-19.

Conclusion: It is important to be aware of the dermatologic manifestations and complications of COVID-19. Knowledge of the components is important to help identify potential COVID-19 patients and properly treat complications.

Keywords: COVID-19; Coronavirus; Dermatology; Emergency medicine; SARS-CoV-2; Skin.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Maculopapular rash.
Fig. 2
Fig. 2
Urticaria.
Fig. 3
Fig. 3
Vesicular rash.
Fig. 4
Fig. 4
Petechial rash.
Fig. 5
Fig. 5
Chilblains of the foot.
Fig. 6
Fig. 6
Livedo reticularis of the lower extremity.
Fig. 7
Fig. 7
Necrotic toe.
See this image and copyright information in PMC

References

    1. World Health Organization Situation report 110. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... Available at.
    1. Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. - PMC - PubMed
    1. Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19 [published online ahead of print, 2020 Apr 18] Am J Emerg Med. 2020 doi: 10.1016/j.ajem.2020.04.048. - DOI - PMC - PubMed
    1. Bridwell R., Long B., Gottlieb M. Neurologic complications of COVID-19 [published online ahead of print, 2020 May 16] Am J Emerg Med. 2020 doi: 10.1016/j.ajem.2020.05.024. - DOI - PMC - PubMed
    1. Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. Jun. - PMC - PubMed